TYME Technologies Inc

06/10/2022

Please click link for more information
https://oasisbreastcancertrial.com/

https://oasisbreastcancertrial.com/

05/10/2022

https://oasisbreastcancertrial.com/

01/04/2022

TYME to present at H.C. Wainwright Bioconnect Virtual Conference on January 10, 2022 / 7:00 AM ET.

Webcast: https://bit.ly/HCWbioconnect_webcast

View the press release at https://bit.ly/HCWbioconnect_pr

12/22/2021

We Want To Wish You A Wonderful Holiday Season and a Happy New Year!

12/14/2021

📣 Update: TYME announces additional encouraging preclinical data on the effect of TYME-19 in SARS CoV-2 infections. Learn More: https://bit.ly/TYME19Update

12/09/2021

TYME oral SM-88 poster accepted for presentation at American Society of Clinical Oncology Symposium. “Oral SM-88 plus MPS, an effective yet less toxic treatment option in second-line advanced ? Final phase II/III study results.”

https://bit.ly/ASCO2022

11/30/2021

NOW ENROLLING: Pancreatic Cancer Action Network trial for patients. 💜

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Full Text View.

11/25/2021

from our at TYME to yours.

11/22/2021

Did you know? Symptoms of are hard to spot - and can even be mistaken for the common health condition heartburn.


https://tymetrials.com

11/10/2021

It’s TYME to conquer ! We have partnered with to create the PanCAN trial for pancreatic cancer patients.

11/02/2021

TYME to present at Jefferies 2021 London Conference on November 17. Details at https://bit.ly/Jefferies21